Ecosystem
Working Together for Greater Impact
TRANSCEND-XR is part of a growing European movement to transform cancer care, not in isolation, but through deep collaboration. Our project is aligned with the European Commission’s Mission on Cancer, which aims to improve the lives of more than 3 million people by 2030 through prevention, treatment, and survivorship support.
We believe real progress happens when people and projects connect. That’s why this page showcases related initiatives, sister projects, and upcoming opportunities that complement or extend the goals of TRANSCEND-XR.
Part of the EU Mission Cancer Framework
TRANSCEND-XR is proud to be a Mission Cancer project funded by the EU’s Horizon Europe research and innovation programme.
Improve cancer prevention and early detection
Accelerate innovative treatments and digital health tools
Enhance quality of life for people living with and beyond cancer
Our focus on testicular cancer survivorship support, powered by extended reality in cancer care, aligns closely with the goals of the Horizon Europe cancer research project cluster working under Mission Cancer.
QoL (AYA) Cluster: A Horizon Europe Collaboration to Improve AYA Cancer Survivorship
TRANSCEND-XR is part of the Quality of Life (Adolescents and Young Adults) Cluster - QoL (AYA) Cluster -, which is a collaboration of Horizon Europe projects that work to improve the quality of life of adolescents and young adults (AYAs) living with and beyond cancer.
The cluster brings together complementary research and innovation initiatives that address the long-term consequences of cancer and its treatment. Although survival rates for young people with cancer are improving, many experience significant late effects that impact their physical health, mental well-being, education, employment, and social participation.
The QoL (AYA) Cluster contributes to a more coordinated European response to these challenges by advancing evidence-based survivorship care, digital health solutions, predictive approaches, and harmonised care pathways.
In line with the goals of the EU Mission on Cancer and Europe's Beating Cancer Plan, the cluster promotes the development of patient-centred, equitable, and sustainable models for long-term cancer care throughout Europe.
Projects in the QoL (AYA) Cluster
The cluster includes the following Horizon Europe projects:
Each project brings something unique to the table, from late-effects research and predictive modelling to digital and immersive health interventions, all of which help to strengthen the European approach to AYA cancer survivorship.
Together, these initiatives aim to improve long-term outcomes for young people affected by cancer, ensuring that quality of life remains a central priority in European cancer policy and research.
Why This Collaboration Matters
By working together, the QoL (AYA) Cluster aims to enhance knowledge exchange, align communication efforts, and maximise the impact of Horizon Europe investment in cancer survivorship.
Through joint dissemination activities, including shared materials and coordinated outreach, the cluster raises awareness of the challenges faced by AYA survivors and encourages engagement with patients, healthcare professionals, policymakers, and research stakeholders across Europe.
Events & Opportunities
Stay informed about upcoming workshops, conferences, and collaborative opportunities across the TRANSCEND-XR network.
25-27 July 2026, Valencia
This conference gathers researchers and practitioners working on digital health systems, healthcare data, and technology-enabled care. Topics include telemedicine, digital interventions, and emerging health technologies that can improve patient engagement and health outcomes.
24–26 September 2026. Hong Kong
UICC's flagship international congress bringing together policymakers, researchers, clinicians, patient advocates and civil society to advance global cancer control.
29 September–1 October 2026. Brussels, Belgium
European Commission flagship event celebrating five years of the EU Cancer Mission. The programme includes project showcases, networking, and sessions on cancer prevention, early detection, quality of life, survivorship, personalised medicine, AI, clinical research and innovation.
One of the world's leading oncology congresses, presenting the latest advances in cancer research, clinical practice, precision medicine and patient care.
18–19 November 2026, Brussels, Belgium & Online
A flagship policy event organised by the European Cancer Organisation bringing together EU institutions, researchers, patient advocates, and industry to discuss progress in Europe’s Beating Cancer Plan and the EU Mission on Cancer.
26–27 November 2026. Lisbon, Portugal
Annual meeting of the European Network of Comprehensive Cancer Centres, focusing on collaboration, excellence in cancer care and implementation of Europe's Beating Cancer Plan.
Want to Collaborate?
Are you working on a project or initiative that aligns with TRANSCEND-XR’s mission?
We’re always open to new partnerships, whether you’re part of a research network, healthcare provider, policymaking body, or patient advocacy group. Let’s explore how we can work together to make survivorship stronger and more supported across Europe.